Search results for "Percutaneous"

showing 10 items of 471 documents

Ultrasound-guided percutaneous treatment of calcific bursitis of the medial collateral ligament of the knee

2021

Calcific bursitis of the medial collateral ligament of the knee is an infrequent pathological condition. In 1988, Kerlan and Glousman identified the clinical features of medial collateral ligament bursitis. Pain and knee functions limitation are the clinical symptoms that are most frequently encountered during the reactive inflammatory process in the bursa, that characterizes the reabsorption phases of the calcific material. It is well documented in the literature that the maximum efficacy of ultrasound-guided percutaneous treatment, with significant reduction or disappearance of symptoms, occurs precisely in this phase. The case report presented in this study confirms the validity as a the…

medicine.medical_specialtyMedial collateral ligamentCase reportsPercutaneousbusiness.industryPhysical Therapy Sports Therapy and Rehabilitationmedicine.diseaseUltrasound guidedCalcificationCalcific bursitismedicineKneeOrthopedics and Sports MedicineRadiologyPhysiologicbusinessMedicina dello Sport
researchProduct

Safety and efficacy of MitraClip™ therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcathete…

2017

Aims The aim of the present study was to assess the safety and efficacy of percutaneous mitral valve repair using the MitraClip™ device in patients with severely reduced systolic left ventricular (LV) function. Methods and results Among 777 MitraClip™ implantations included in the German mitral valve registry, we identified 256 patients suffering from severely reduced LV function [ejection fraction (EF) 50%) and 280 patients presenting with an EF 30–50% prior to MitraClip™ therapy. High procedural success rates, low periprocedural complication rates, and low residual mitral regurgitation grades at discharge were achieved throughout all groups. In-hospital mortality was low and comparable in…

medicine.medical_specialtyMitral regurgitationEjection fractionbusiness.industryMortality rateMitraClip030204 cardiovascular system & hematologymedicine.disease3. Good healthSurgery03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureInternal medicineMitral valveHeart failuremedicineCardiology030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessComplicationPercutaneous Mitral Valve RepairEuropean Journal of Heart Failure
researchProduct

Mitral valve therapy still surgical?

2015

Mitral regurgitation (MR) is the second most common valvular heart disease after aortic valve stenosis. With increased understanding of the heterogenic pathophysiology of MR, cardiac surgeons have developed various techniques that increase the likelihood of successful mitral valve repair (MVR). Nowadays, a rate of repair >90% may be reached in some mitral valve reference centres. In recent years, the introduction of transcatheter mitral valve intervention techniques has opened up new frontiers in mitral therapy, specifically in patients at high risk for standard surgery. Current percutaneous technologies for MVR have been developed on the basis of some of the surgical principles. Based on c…

medicine.medical_specialtyMitral valve repairMitral regurgitationPercutaneousbusiness.industryClinical outcomemedicine.medical_treatmentStandard treatmentMitraClipNew devicevalvular heart diseasemedicine.diseasemedicine.anatomical_structureAortic valve stenosisInternal medicineMitral valvecardiovascular systemmedicineCardiologyTranscatheter mitral valve therapybusinessCardiology and Cardiovascular MedicineMitral valve repairLong-term repair result
researchProduct

Gender-related disparities in the treatment and outcomes in patients with non-ST-segment elevation myocardial infarction: results from the Polish Reg…

2017

Introduction: Gender-related differences in the treatment of patients with non-ST elevation myocardial infarction (NSTEMI) have been reported in many previous studies despite the fact that an equal approach is recommended in all current guidelines. The aim of the study was to investigate whether gender-related discrepancies in the management of NSTEMI patients have changed. Material and methods: Between 2012 and 2014 a total of 66,667 patients (38.3% of whom were women) with the final diagnosis of NSTEMI were included into the retrospective analysis of the Polish Registry of Acute Coronary Syndromes (PL-ACS). Differences in clinical profile, treatment, and outcomes were analysed. Results: W…

medicine.medical_specialtyMultivariate analysismedicine.medical_treatmentAge adjustmentPopulationelderly03 medical and health sciences0302 clinical medicineClinical ResearchInternal medicinemedicineST segment030212 general & internal medicineMyocardial infarctioneducationeducation.field_of_studybusiness.industryMortality rateinvasive treatmentPercutaneous coronary interventionGeneral Medicinemedicine.diseaseGender relatedmortalitynon-ST elevation myocardial infarctionwomenbusinessArchives of Medical Science
researchProduct

Annual Trends in Total Ischemic Time and One-Year Fatalities: The Paradox of STEMI Network Performance Assessment

2019

This study is aimed at assessing trends and relations between total ischemic time, the major quality measure of systemic delay, and case-fatality at the population or patient level in response to growing cardiovascular risk and a constant need to shorten the time to treatment in ST-segment elevation myocardial infarction (STEMI). Data from a prospective nationwide registry of STEMI patients admitted between 2006 and 2013 who were treated with primary percutaneous coronary intervention (PCI) were analyzed. Total ischemic time was calculated as the time from the onset of symptoms to primary PCI and was determined as individual and annual. The primary end-point was one-year, all-cause case-fat…

medicine.medical_specialtyMultivariate analysismedicine.medical_treatmentPopulationlcsh:MedicineIschemic time030204 cardiovascular system & hematologyArticleSTEMI03 medical and health sciencestotal ischemic time0302 clinical medicineInternal medicineCase fatality ratemedicinecase-fatality030212 general & internal medicineMyocardial infarctioncardiovascular diseasesRisk factoreducationeducation.field_of_studybusiness.industrylcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseConventional PCInetworkCardiologybusinessJournal of Clinical Medicine
researchProduct

Differences in patients and lesion and procedure characteristics depending on the age of the coronary chronic total occlusion

2018

Introduction: Whether duration of chronic total occlusion (CTO) affects lesion and procedural characteristics remains largely unknown. Aim: To investigate whether CTO duration influences lesion characteristics and revascularization success. Material and methods: EuroCTO Registry data on patients who had CTO percutaneous coronary intervention between January 2015 and April 2017 were analyzed. Three groups were created based on occlusion age: 3 to 6 months (n = 1415), 7 to 12 months (n = 973), > 12 months (n = 1656). Results: Patients with greater CTO duration were older (63.0 (56.0–70.0); 63.0 (56.0–71.0); 66.0 (59.0–73.0) years respectively; p < 0.001), had more 3-vessel disease (32.2…

medicine.medical_specialtyMultivariate analysismedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyRevascularizationlesion characteristicsPercutaneous coronary intervention.Lesion03 medical and health sciences0302 clinical medicineInternal medicineOcclusionMedicine030212 general & internal medicineLesion characteristicAdverse effectchronic total occlusionOriginal Paperbusiness.industrypercutaneous coronary interventionlcsh:RPercutaneous coronary interventionCollateral circulationmedicine.anatomical_structureCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessArtery
researchProduct

Myocardial Infarction in Centenarians. Data from The Polish Registry of Acute Coronary Syndromes

2020

Background: There are no data regarding the mortality rate, risks and benefits of particular reperfusion methods and pharmacological treatment complications in patients aged over 100 years with acute coronary syndromes. We sought to assess the treatment of myocardial infarction (MI) in patients older than 100 years and to determine prognostic factors for this group. Methods: Among the 716,566 patients recorded between 2003 and 2018 in the Polish Registry of Acute Coronary Syndromes, 104 patients aged &ge

medicine.medical_specialtyMultivariate analysismedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyelderlyArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicine030212 general & internal medicineMyocardial infarctionStrokeEjection fractionbusiness.industryMortality ratelcsh:RHazard ratiopercutaneous coronary interventionPercutaneous coronary interventionGeneral Medicinemyocardial infarction; elderly; centenarians; percutaneous coronary interventionmedicine.diseaseConfidence intervalmyocardial infarctionCardiologycentenariansbusinessJournal of Clinical Medicine
researchProduct

Tissue characterization comparison of culprit lesions between stable coronary disease and ST elevation myocardial infarction patients

2013

medicine.medical_specialtyNecrosisbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionTissue characterizationCoronary diseasemedicine.diseaseCulpritAtheromaSt elevation myocardial infarctionInternal medicineFactor V LeidenmedicineCardiologyRadiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Inclusión de la inyección percutánea de etanol como primera línea de tratamiento de los quistes tiroideos sintomáticos

2021

Abstract Background Our aim was to evaluate the efficacy and security of ultrasound-guided percutaneous ethanol injection therapy (US-PEIT) for the treatment of recurrent symptomatic thyroid cysts in two high-resolution consultations of thyroid nodule in the Valencian Community. Patients and methods The study comprised thirty-three consecutive patients (51 ± 12 years, 76% women) with symptomatic benign thyroid cysts relapsed after drainage and benign cytology prior to treatment. Through ultrasound, maximum cyst diameter and volume were determined, and the content of the cyst was drained. We then instilled between 2 and 4 ml of ethanol (according to initial volume). We followed up with ultra…

medicine.medical_specialtyNutrition and DieteticsMild painVisual analogue scalebusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentThyroidUltrasound030209 endocrinology & metabolismmedicine.disease030218 nuclear medicine & medical imagingSurgery03 medical and health sciences0302 clinical medicineEndocrinologymedicine.anatomical_structureCytologymedicineVolume reductionCystPercutaneous ethanol injectionbusinessEndocrinología, Diabetes y Nutrición
researchProduct

Percutaneous osteoplasty in treatment of bone lymphangiomatosis

2013

Primary bone lymphangiomatosis is a disease of unknown etiology that can cause lytic lesions in long bones, the pelvis, the spinal column and the cranium. We are presenting the case of a woman with localized bone lymphangiomatosis in the left knee. The authors believe this is the first case in which percutaneous osteoplasty was used in long bones for the treatment of bone lesions resulting from this disease showing good clinical results.

medicine.medical_specialtyOsteoplastyPercutaneouskneeCase Reportosteoplastylymphangiomatosislcsh:Orthopedic surgerymedicineOrthopedics and Sports MedicineBoneLymphangiomatosisPelvisbusiness.industrymedicine.diseaseSpinal columnSurgerylcsh:RD701-811Primary bonemedicine.anatomical_structurepercutaneousOrthopedic surgeryPercutaneous OsteoplastyRadiologybusiness
researchProduct